Clinical Trial Update: A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF) [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial (CONFIRMATION-HF) is evaluating the efficacy and safety of combining finerenone with a SGLT2 inhibitor in hospitalized heart failure …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Kerendia (finerenone)
• SGLT2 inhibitor

Snippet

Sponsor: Colorado Prevention Center | Conditions: Heart Failure | Phase 3 | Status: RECRUITING